ATE303152T1 - Neuroprotektive 7-beta-hydroxysteroide - Google Patents

Neuroprotektive 7-beta-hydroxysteroide

Info

Publication number
ATE303152T1
ATE303152T1 AT01945490T AT01945490T ATE303152T1 AT E303152 T1 ATE303152 T1 AT E303152T1 AT 01945490 T AT01945490 T AT 01945490T AT 01945490 T AT01945490 T AT 01945490T AT E303152 T1 ATE303152 T1 AT E303152T1
Authority
AT
Austria
Prior art keywords
hydroxysteroids
neuroprotection
beta
hydroxy
steroids
Prior art date
Application number
AT01945490T
Other languages
English (en)
Inventor
Ernst Wuelfert
Ashley Ker Pringle
Lars Eric Sundstrom
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Application granted granted Critical
Publication of ATE303152T1 publication Critical patent/ATE303152T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01945490T 2000-06-29 2001-06-29 Neuroprotektive 7-beta-hydroxysteroide ATE303152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0016027A GB2363984A (en) 2000-06-29 2000-06-29 Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
PCT/GB2001/002929 WO2002000224A1 (en) 2000-06-29 2001-06-29 Neuroprotective 7-beta-hydroxysteroids

Publications (1)

Publication Number Publication Date
ATE303152T1 true ATE303152T1 (de) 2005-09-15

Family

ID=9894710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945490T ATE303152T1 (de) 2000-06-29 2001-06-29 Neuroprotektive 7-beta-hydroxysteroide

Country Status (23)

Country Link
US (2) US20030186953A1 (de)
EP (1) EP1294381B1 (de)
JP (1) JP2004501195A (de)
KR (1) KR100829490B1 (de)
CN (1) CN100441189C (de)
AT (1) ATE303152T1 (de)
AU (2) AU6770501A (de)
CA (1) CA2414583C (de)
CY (1) CY1105371T1 (de)
CZ (1) CZ305306B6 (de)
DE (1) DE60113112T2 (de)
DK (1) DK1294381T3 (de)
ES (1) ES2247141T3 (de)
GB (1) GB2363984A (de)
HK (1) HK1052299B (de)
HU (1) HU229265B1 (de)
IL (2) IL153540A0 (de)
NO (1) NO332089B1 (de)
PL (1) PL200698B1 (de)
RU (1) RU2258511C2 (de)
SI (1) SI1294381T1 (de)
WO (1) WO2002000224A1 (de)
ZA (1) ZA200210214B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
EP2298315A1 (de) * 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutische Behandlungsmethoden
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
ZA200704889B (en) * 2004-11-23 2008-09-25 Celgene Corp JNK inhibitors for treatment of CNS injury
DK2792681T3 (en) * 2006-11-21 2017-01-23 Umecrine Ab Use of Pregnancy and Androstan Steroids in the Preparation of a Pharmaceutical Composition for the Treatment of CNS Disorders.
EP2097079B1 (de) * 2006-11-30 2012-06-27 Hunter-Fleming Limited Modulierung des prostaglandin/cyclooxygenase-metabolismus
GB0623971D0 (en) * 2006-11-30 2007-01-10 Hunter Fleming Ltd Modulation of prostaglandin/cyclooxygenase metabolic pathways
CZ2008434A3 (cs) * 2008-07-10 2009-12-09 Ústav organické chemie a biochemie Akademie ved CR, v. v. i. Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
DE102012001361A1 (de) 2012-01-24 2013-07-25 Linde Aktiengesellschaft Verfahren zum Kaltgasspritzen
US20160362442A1 (en) * 2015-06-10 2016-12-15 IronMag Labs Method For DHEA Enanthate Processing

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
ATE283052T1 (de) * 1993-03-09 2004-12-15 Univ Utah Res Found Verwendung von dhea oder dessen derivate zur herstellung eines medikaments zur vorbeugung von progressiver gewebe-nekrose, reperfusionsschädigung, bakterieller translokation und vom atemnotsyndrom bei erwachsenen
ATE284895T1 (de) * 1995-06-06 2005-01-15 Euro Celtique Sa Neuroaktive steroide der androstan- und pregnanreihe
GB2317826B (en) * 1995-08-29 1999-12-15 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
CN1222851A (zh) * 1996-04-09 1999-07-14 英国技术集团国际有限公司 7α－取代的类固醇用于治疗神经精神病、免疫或内分泌疾病的用途
DE69737791D1 (de) * 1996-04-09 2007-07-19 Univ Edinburgh Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen
JP2001500852A (ja) * 1996-08-27 2001-01-23 プレーシス ファーマスーティカルズ インコーポレイテッド Ｄ―アミノ酸を含むβ―アミロイドペプチド凝集のモジュレーター
RU2142802C1 (ru) * 1997-02-13 1999-12-20 Обут Тимофей Александрович Гипотензивное средство
US6544972B1 (en) * 1997-09-25 2003-04-08 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO1999024400A1 (en) * 1997-11-10 1999-05-20 Vyrex Corporation Probucol esters and uses thereof
EP1032397A1 (de) * 1997-11-24 2000-09-06 University Of Florida Research Foundation, Inc. Testosterone inhibitoren und verwendung zum neuronalschutz
WO1999052532A1 (en) * 1998-04-14 1999-10-21 Pharmadigm, Inc. Method for reducing central nervous system impairment
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
PT1226155E (pt) * 1999-11-02 2007-07-26 Bayer Schering Pharma Ag 18-nor-esteróides como estrogénios selectivamente activos
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone

Also Published As

Publication number Publication date
CA2414583C (en) 2010-08-24
US20100130459A1 (en) 2010-05-27
EP1294381A1 (de) 2003-03-26
IL153540A0 (en) 2003-07-06
NO20026244L (no) 2003-02-27
HK1052299B (en) 2006-01-27
NO20026244D0 (no) 2002-12-27
EP1294381B1 (de) 2005-08-31
SI1294381T1 (sl) 2006-04-30
CY1105371T1 (el) 2010-04-28
AU6770501A (en) 2002-01-08
GB0016027D0 (en) 2000-08-23
WO2002000224A1 (en) 2002-01-03
ES2247141T3 (es) 2006-03-01
IL153540A (en) 2008-07-08
PL200698B1 (pl) 2009-01-30
AU2001267705B2 (en) 2005-08-18
JP2004501195A (ja) 2004-01-15
HUP0301317A3 (en) 2006-06-28
CN100441189C (zh) 2008-12-10
PL359105A1 (en) 2004-08-23
US20030186953A1 (en) 2003-10-02
HUP0301317A2 (hu) 2003-08-28
DE60113112T2 (de) 2006-07-13
DK1294381T3 (da) 2005-10-31
ZA200210214B (en) 2004-03-17
CZ305306B6 (cs) 2015-07-22
NO332089B1 (no) 2012-06-18
HU229265B1 (en) 2013-10-28
KR20030034112A (ko) 2003-05-01
KR100829490B1 (ko) 2008-05-16
DE60113112D1 (de) 2005-10-06
CN1443071A (zh) 2003-09-17
RU2258511C2 (ru) 2005-08-20
CA2414583A1 (en) 2002-01-03
HK1052299A1 (en) 2003-09-11
GB2363984A (en) 2002-01-16

Similar Documents

Publication Publication Date Title
DE60010098D1 (de) 28-epirapaloge
LU92057I2 (fr) Vandétanib (CAPRELSA)
NO20002026L (no) Tilbaketrekkingssnelle for nøkler og lignende
NO20020275D0 (no) Imidazoimidazoler og -triazoler som anti-inflammatoriske midler
LU92381I2 (fr) Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT)
DE50006732D1 (de) Gassack-Schutzeinrichtung
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
DE50015420D1 (de) Gassack-Schutzeinrichtung
ATE303152T1 (de) Neuroprotektive 7-beta-hydroxysteroide
DE60014955D1 (de) Schraubzange
FI20000508L (fi) Murskain
ATE401897T1 (de) 7-hydroxyepiandrosteron mit neuroprotektiver wirkung
AU2002223655A1 (en) Indolylpiperidine derivatives as antihistaminic and antiallergic agents
AU2001291877A1 (en) N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent againstparasitic protozoans
DE60036356D1 (de) Düse sowie zugehöriger Absauger
AU2000262864A1 (en) Shelter for protection against hail
DE60045605D1 (de) Transformator,Lautsprechervorrichtung und Lautsprechersystem
DE60118970D1 (de) Indol- und dihydroindolderivate
NO20021475D0 (no) Vasopressinantagonist, formulering og fremgangsmåte
FI20010377L (fi) Suojakotelo mikrofoneja varten
FI4480U1 (fi) Hienonnuslaite
DE59905993D1 (de) Abschaltkupplung
FI991388A0 (fi) Karamurskain
AU2002222093A1 (en) Goggles and masks
IT1312568B1 (it) Peptidi immunogenici e loro uso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1294381

Country of ref document: EP